Effects of drugs on the dopamine mechanisms in the corpus striatum and in the limbic system and on the noradrenaline and 5-hydroxytryptamine mechanisms in the spinal cord
Publisher
Macmillan Education UK
Reference37 articles.
1. Andén, N.-E. (1966). ‘On the function of the nigro-neostriatal dopamine pathway’, in Mechanisms of Release of Biogenic Amines (Euler, U. S.v., Rosell, S. and Uvnäs, B., Eds.), 357–359, Pergamon Press, Oxford 2. Andén, N.-E. (1968). ‘Discussion of serotonin and dopamine in the extrapyramidal system’, Adv. Pharmac., 6A, 347–349 3. Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K. and Ungerstedt, U. (1970a). ‘Receptor activity and turnover of dopamine and noradrenaline after neuroleptics’, Eur. J. Pharmac., 11, 303–314 4. Andén, N.-E., Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.-A. and Larsson, K. (1964a). ‘Demonstration and mapping out of nigro-neostriatal dopamine neurons’, Life Sci., 3, 523–530 5. Andén, N.-E., Corrodi, H. and Fuxe, K. (1971). ‘Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons’, J. Pharmac. exp. Ther., 179, 236–249
|
|